“I would hope that they are processing a progressive analysis of the other endpoints as patients finish Day 28, including Dr.BP's companion assays which we know are being performed, but which are not technically included in the trial protocol.”

Same, but I’m confused by the difference between a interim analysis at 50% enrollment and vs a periodic safety review conducted by a DSMC (which is what CYDY will be doing next week). Is. A progressive analysis of the other endpoints part of the safety review, or is it just deaths and other SAEs?